STA R Max 3, STA Compact Max 3
510(k) K212183
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK212183 | Date7 Jun 2023 | StatusActive |
| European Union | CE/IVDR EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- JPA
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.5425
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The STA R Max 3 and STA Compact Max 3 are multipurpose in vitro coagulation study systems designed for hematological analysis. These devices perform automated coagulation testing, including prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and other related assays to evaluate blood clotting parameters.
These systems are intended for use in clinical laboratories and are supplied as reusable medical devices. They are classified under Class II (Device Class 2) and comply with FDA 510K clearance and IVDR regulations. The STA R Max 3 and STA Compact Max 3 feature multiple assay capabilities, with specific reference codes and registration numbers listed for regulatory tracking. They require proper maintenance and calibration to ensure accurate results.
Other devices from Diagnostica Stago S.A.S
Questions
AI-generated answers, 18 Sep 2026
Are the STA R Max 3 and STA Compact Max 3 systems designed for single-use or repeated use in a clinical setting?
The STA R Max 3 and STA Compact Max 3 are reusable medical devices intended for clinical laboratories. Since they are classified as Class II devices and require maintenance and calibration, they are not single-use but are engineered for prolonged use with proper upkeep to ensure accurate coagulation testing results.
What types of coagulation tests can these systems perform, and why is this important for hematology labs?
The STA R Max 3 and STA Compact Max 3 systems automate key coagulation assays, including prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and related tests to evaluate blood clotting parameters. This is critical for hematology labs because these tests help diagnose bleeding disorders, monitor anticoagulant therapy (e.g., warfarin), and assess clotting dysfunctions, ensuring precise patient management.
How do I determine which registration number applies to my specific STA R Max 3 or STA Compact Max 3 unit?
Each unit has a unique registration number listed in the provided data (e.g., `3015222335`, `3010653929`, etc.), which corresponds to its regulatory filing. To identify the correct number, check the device’s label, documentation, or contact Diagnostica Stago’s support team (e.g., Pauline Vasselon) for verification, as these numbers track compliance and maintenance history.
Do these systems require any special storage conditions, and if so, why?
While the data does not specify exact storage conditions, reusable medical devices like these typically require clean, controlled environments (e.g., protected from dust, extreme temperatures, or humidity) to prevent contamination or mechanical damage. Proper storage ensures longevity, calibration accuracy, and compliance with maintenance protocols for reliable coagulation testing.
What is the regulatory pathway for these devices, and how does it affect their use in the U.S.?
The STA R Max 3 and STA Compact Max 3 received FDA 510(k) clearance under the Traditional pathway (K212183) and comply with IVDR regulations. This means they are classified as Class II devices and have undergone premarket review to demonstrate substantial equivalence to predicate devices, ensuring their safety and effectiveness for automated coagulation testing in clinical labs.